ZhuZhou QianJin Pharmaceutical Co Ltd Capital Reinvestment Ratio
ZhuZhou QianJin Pharmaceutical Co Ltd capital reinvestment ratio. ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥288.83 Million) in capital expenditures (CN¥23.89 Million). Check ZhuZhou QianJin Pharmaceutical Co Ltd (600479) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Capital reinvestment ratio of ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2025. This chart tracks ZhuZhou QianJin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Also explore 600479 net assets growth trend to track the company's year-over-year net asset growth rate.
ZhuZhou QianJin Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2002–2025)
ZhuZhou QianJin Pharmaceutical Co Ltd capital reinvestment ratio by year from 2002 to 2025. For the full cash flow conversion analysis, see ZhuZhou QianJin Pharmaceutical Co Ltd (600479) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | CN¥480.24 Million | CN¥124.17 Million | ▲ +117.9% |
| 2024 | 0.12x | CN¥398.77 Million | CN¥47.32 Million | ▲ +19.5% |
| 2023 | 0.10x | CN¥443.12 Million | CN¥43.99 Million | ▲ +111.5% |
| 2022 | 0.05x | CN¥733.47 Million | CN¥34.43 Million | ▼ -68.3% |
| 2021 | 0.15x | CN¥485.57 Million | CN¥71.88 Million | ▼ -17.4% |
| 2020 | 0.18x | CN¥542.37 Million | CN¥97.24 Million | ▼ -31.4% |
| 2019 | 0.26x | CN¥155.49 Million | CN¥40.61 Million | ▲ +115.9% |
| 2018 | 0.12x | CN¥383.47 Million | CN¥46.39 Million | ▼ -40.2% |
| 2017 | 0.20x | CN¥283.47 Million | CN¥57.30 Million | ▼ -65.1% |
| 2016 | 0.58x | CN¥140.88 Million | CN¥81.50 Million | ▼ -53.8% |
| 2015 | 1.25x | CN¥67.48 Million | CN¥84.47 Million | ▲ +247.9% |
| 2014 | 0.36x | CN¥183.34 Million | CN¥65.97 Million | ▼ -41.2% |
| 2013 | 0.61x | CN¥137.63 Million | CN¥84.26 Million | ▼ -52.7% |
| 2012 | 1.30x | CN¥197.82 Million | CN¥256.26 Million | ▼ -54.2% |
| 2011 | 2.83x | CN¥22.58 Million | CN¥63.87 Million | ▲ +89.4% |
| 2010 | 1.49x | CN¥39.13 Million | CN¥58.44 Million | ▼ -10.9% |
| 2009 | 1.68x | CN¥73.54 Million | CN¥123.31 Million | ▼ -34.5% |
| 2008 | 2.56x | CN¥37.20 Million | CN¥95.30 Million | ▲ +801.0% |
| 2007 | 0.28x | CN¥79.26 Million | CN¥22.53 Million | ▲ +59.7% |
| 2006 | 0.18x | CN¥120.12 Million | CN¥21.39 Million | ▼ -18.6% |
| 2005 | 0.22x | CN¥76.50 Million | CN¥16.74 Million | ▼ -92.9% |
| 2004 | 3.06x | CN¥18.45 Million | CN¥56.50 Million | ▲ +358.2% |
| 2003 | 0.67x | CN¥50.96 Million | CN¥34.05 Million | ▼ -93.1% |
| 2002 | 9.75x | CN¥6.07 Million | CN¥59.24 Million | — |